Short Interest in Femasys Inc. (NASDAQ:FEMY) Grows By 124.1%

Femasys Inc. (NASDAQ:FEMY) was the recipient of a large growth in short interest during the month of March. As of March 15th, there was short interest totalling 1,120,000 shares, a growth of 124.1% from the February 29th total of 499,700 shares. Approximately 5.6% of the company’s stock are sold short. Based on an average daily trading volume, of 680,100 shares, the short-interest ratio is presently 1.6 days.

Analysts Set New Price Targets

FEMY has been the subject of a number of analyst reports. HC Wainwright reissued a “buy” rating and issued a $10.00 price objective on shares of Femasys in a research report on Thursday, March 21st. Chardan Capital reissued a “buy” rating and issued a $12.00 price objective on shares of Femasys in a report on Thursday, March 21st. Finally, Jonestrading boosted their target price on shares of Femasys from $7.00 to $10.00 and gave the company a “buy” rating in a research report on Wednesday, March 20th.

Femasys Price Performance

Shares of NASDAQ:FEMY traded up $0.08 during midday trading on Thursday, hitting $1.55. The stock had a trading volume of 436,717 shares, compared to its average volume of 711,122. The company’s 50-day moving average price is $1.39 and its 200-day moving average price is $1.20. The company has a market capitalization of $33.56 million, a P/E ratio of -1.68 and a beta of -2.95. The company has a quick ratio of 4.40, a current ratio of 4.68 and a debt-to-equity ratio of 0.01. Femasys has a fifty-two week low of $0.25 and a fifty-two week high of $4.75.

Hedge Funds Weigh In On Femasys

Institutional investors have recently added to or reduced their stakes in the stock. Vanguard Personalized Indexing Management LLC acquired a new position in Femasys during the 3rd quarter worth approximately $35,000. Cetera Advisor Networks LLC acquired a new position in Femasys during the 1st quarter worth approximately $27,000. Virtu Financial LLC acquired a new position in Femasys during the 2nd quarter worth approximately $39,000. LPL Financial LLC acquired a new position in Femasys during the 2nd quarter worth approximately $51,000. Finally, Wealthspire Advisors LLC bought a new stake in Femasys during the 3rd quarter worth approximately $84,000. 65.27% of the stock is currently owned by institutional investors and hedge funds.

About Femasys

Femasys Inc, a biomedical company, develops novel solutions for women's healthcare market in the United States and internationally. The company provides FemVue saline-air device, a contrast-generating product in the United States, Canada, Japan, and Hong Kong; FemCath, a cornual balloon catheter, a single intrauterine directional delivery product that allows for selective evaluation of an individual fallopian tube; and FemCerv, a biopsy device for endocervical curettage, which can be used to sample cervical cells and tissue circumferentially with sample containment within the device to minimize contamination.